• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Lu-DOTMP诱导MG63细胞系发生G2/M期细胞周期阻滞和细胞凋亡。

Lu-DOTMP induces G2/M cell cycle arrest and apoptosis in MG63 cell line.

作者信息

Kumar Chandan, Sharma Rohit, Das Tapas, Korde Aruna, Sarma Haladhar, Banerjee Sharmila, Dash Ashutosh

机构信息

Radiopharmaceuticals Division, Bhabha Atomic Research Centre, Mumbai, India.

Radiation Biology & Health Sciences Division, Bhabha Atomic Research Centre, Mumbai, India.

出版信息

J Labelled Comp Radiopharm. 2018 Sep;61(11):837-846. doi: 10.1002/jlcr.3651. Epub 2018 Jul 11.

DOI:10.1002/jlcr.3651
PMID:29923620
Abstract

Bone pain is the major manifestation of skeletal metastases. Although various treatment modalities are available for bone pain palliation, use of radiolabeled phosphonates is documented to be more effective. Among radionuclides available for this purpose, lutetium-177 is gaining popularity due to its moderate beta energy, theranostic capability, favorable half-life and convenient production logistics. Lu-DOTMP has shown considerable promise as a metastatic bone pain palliating agent in preliminary evaluations and recent clinical studies. Therefore, an attempt was made to elucidate the possible mechanism of in vitro cell death induced by Lu-DOTMP in MG63 cells. Lu-DOTMP binding studies were carried out in mineralized bone of MG63 cells and around 50% binding was observed. Skeletons of Wistar rats showed 1.78 ± 0.5% IA/g at a 3 h time period which was almost constant up to 7 days. MG63 cells were incubated with 3.7 and 37 MBq of Lu-DOTMP for 48 h prior to perform assays. An increase in the magnitude of cell toxicity and apoptotic DNA fragmentation was observed. Enhancement of G2/M phase cell cycle arrest and apoptosis were documented which were dose-dependent. Thus, Lu-DOTMP induced apoptotic cell death in MG63 cells, which might be one of the primary causes of pain relief in osseous metastases.

摘要

骨痛是骨转移的主要表现。尽管有多种治疗方式可用于缓解骨痛,但已证明使用放射性标记的膦酸盐更为有效。在可用于此目的的放射性核素中,镥-177因其适度的β能量、诊疗能力、良好的半衰期和便捷的生产物流而越来越受欢迎。在初步评估和近期临床研究中,镥-二甲基膦酸五甲酯(Lu-DOTMP)作为一种转移性骨痛缓解剂已显示出相当大的前景。因此,人们试图阐明Lu-DOTMP在MG63细胞中诱导体外细胞死亡的可能机制。在MG63细胞的矿化骨中进行了Lu-DOTMP结合研究,观察到约50%的结合率。在3小时时间段内,Wistar大鼠骨骼的摄取量为1.78±0.5%注射活度/克,直至7天几乎保持恒定。在进行检测之前,将MG63细胞与3.7和37MBq的Lu-DOTMP孵育48小时。观察到细胞毒性程度和凋亡性DNA片段化增加。记录到G2/M期细胞周期阻滞和凋亡增强,且呈剂量依赖性。因此,Lu-DOTMP在MG63细胞中诱导凋亡性细胞死亡,这可能是骨转移疼痛缓解的主要原因之一。

相似文献

1
Lu-DOTMP induces G2/M cell cycle arrest and apoptosis in MG63 cell line.Lu-DOTMP诱导MG63细胞系发生G2/M期细胞周期阻滞和细胞凋亡。
J Labelled Comp Radiopharm. 2018 Sep;61(11):837-846. doi: 10.1002/jlcr.3651. Epub 2018 Jul 11.
2
A "mix-and-use" approach for formulation of human clinical doses of Lu-DOTMP at hospital radiopharmacy for management of pain arising from skeletal metastases.一种在医院放射性药房配制用于治疗骨转移引起疼痛的临床剂量镥- DOTMP的“混合使用”方法。
J Labelled Comp Radiopharm. 2017 Jul;60(9):410-419. doi: 10.1002/jlcr.3517. Epub 2017 Jun 21.
3
Camptothecin Enhances Cell Death Induced by (177)Lu-EDTMP in Osteosarcoma Cells.喜树碱增强(177)Lu-EDTMP诱导骨肉瘤细胞的细胞死亡。
Cancer Biother Radiopharm. 2014 Oct;29(8):317-22. doi: 10.1089/cbr.2014.1663. Epub 2014 Sep 16.
4
177Lu-labeled cyclic polyaminophosphonates as potential agents for bone pain palliation.177镥标记的环状聚氨基膦酸盐作为缓解骨痛的潜在药物。
Appl Radiat Isot. 2002 Aug;57(2):177-84. doi: 10.1016/s0969-8043(02)00104-5.
5
Comparative studies of 177Lu-EDTMP and 177Lu-DOTMP as potential agents for palliative radiotherapy of bone metastasis.177镥-乙二胺四甲基膦酸(177Lu-EDTMP)和177镥-二巯基丁二酸(177Lu-DOTMP)作为骨转移姑息性放疗潜在药物的比较研究。
Appl Radiat Isot. 2008 Sep;66(9):1196-205. doi: 10.1016/j.apradiso.2008.02.061. Epub 2008 Feb 17.
6
Induction of different cellular arrest and molecular responses in low EGFR expressing A549 and high EGFR expressing A431 tumor cells treated with various doses of Lu-Nimotuzumab.用不同剂量的 Lu-Nimotuzumab 处理低表达 EGFR 的 A549 和高表达 EGFR 的 A431 肿瘤细胞,诱导不同的细胞阻滞和分子反应。
Int J Radiat Biol. 2020 Sep;96(9):1144-1156. doi: 10.1080/09553002.2020.1793012. Epub 2020 Jul 23.
7
Cellular toxicity and apoptosis studies in osteocarcinoma cells, a comparison of 177Lu-EDTMP and Lu-EDTMP.骨肉瘤细胞的细胞毒性和凋亡研究:177Lu-EDTMP与Lu-EDTMP的比较
Curr Radiopharm. 2013 Sep;6(3):146-51. doi: 10.2174/18744710113069990021.
8
Dose-dependent cell cycle arrest and apoptosis in HER2 breast cancer cells byLu-CHX-A"-DTPA-Trastuzumab.Lu-CHX-A"-DTPA-Trastuzumab 诱导 HER2 阳性乳腺癌细胞的剂量依赖性细胞周期阻滞和凋亡
J Cancer Res Ther. 2020 Oct-Dec;16(6):1426-1434. doi: 10.4103/jcrt.JCRT_20_19.
9
Formulation, preclinical evaluation, and preliminary clinical investigation of an in-house freeze-dried EDTMP kit suitable for the preparation of 177Lu-EDTMP.适用于制备177Lu-EDTMP的自制冻干EDTMP试剂盒的配方、临床前评估及初步临床研究
Cancer Biother Radiopharm. 2014 Dec;29(10):412-21. doi: 10.1089/cbr.2014.1664.
10
Assessment of cell death mechanisms triggered by Lu-anti-CD20 in lymphoma cells.评估镥标记抗CD20在淋巴瘤细胞中引发的细胞死亡机制。
Appl Radiat Isot. 2018 Aug;138:73-77. doi: 10.1016/j.apradiso.2017.04.016. Epub 2017 Apr 12.

引用本文的文献

1
Radiobioconjugate of Kadcyla with Radioactive Gold Nanoparticles for Targeted Therapy of HER2-Overexpressing Cancers.用于HER2过表达癌症靶向治疗的、曲妥珠单抗偶联物与放射性金纳米颗粒的放射生物共轭物
Mol Pharm. 2025 Jul 7;22(7):4019-4031. doi: 10.1021/acs.molpharmaceut.5c00288. Epub 2025 May 29.
2
DNA Damage by Radiopharmaceuticals and Mechanisms of Cellular Repair.放射性药物所致DNA损伤及细胞修复机制
Pharmaceutics. 2023 Dec 12;15(12):2761. doi: 10.3390/pharmaceutics15122761.
3
A review of advances in the last decade on targeted cancer therapy using Lu: focusing on Lu produced by the direct neutron activation route.
过去十年间镥在靶向癌症治疗方面的进展综述:聚焦于通过直接中子活化途径产生的镥。
Am J Nucl Med Mol Imaging. 2021 Dec 15;11(6):443-475. eCollection 2021.